EIM
IMI

Essex Investment Management’s Intermolecular, Inc. IMI Stock Holding History

Essex Investment Management’s Portfolio IMI Stock Details IMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-153,485
Closed -$256K – 453
2018
Q2 		$256K Hold
153,485
– – 0.03% 353
2018
Q1 		$201K Sell
153,485
-15,536
-9% -$22.1K 0.03% 350
2017
Q4 		$232K Buy
+169,021
New +$203K 0.03% 336

Other funds holding IMI

RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Essex Investment Management's IMI Position: Q3 2018 in Review

Essex Investment Management sold out of Intermolecular, Inc. (IMI) in Q3 2018, closing a stake of 153,485 shares — an estimated $256K sold.

Essex Investment Management first reported a position in IMI in Q4 2017 and held it in 3 quarters. The position peaked at $256K in Q2 2018. 28 funds tracked by Wall St. Rank hold IMI as of Q3 2018.

  • Essex Investment Management reported no remaining Intermolecular, Inc. position as of Q3 2018 after selling out during the quarter.
  • Essex Investment Management sold 153,485 Intermolecular, Inc. shares in Q3 2018, an estimated $256K.
  • Essex Investment Management first reported a position in Intermolecular, Inc. in Q4 2017 and held it in 3 quarters.
  • Essex Investment Management's Intermolecular, Inc. position peaked at $256K in Q2 2018.
  • 28 funds tracked by Wall St. Rank held Intermolecular, Inc. as of Q3 2018.

Based on Essex Investment Management's 13F filing for Q3 2018, filed 16 Oct 2018.